TY - JOUR
T1 - Accuracy of Intraoperative Frozen Section Diagnosis of Borderline Ovarian Tumors by Hospital Type
AU - Shah, Jaimin S.
AU - Mackelvie, Michael
AU - Gershenson, David M.
AU - Ramalingam, Preetha
AU - Kott, Marylee M.
AU - Brown, Jubilee
AU - Gauthier, Polly
AU - Nugent, Elizabeth
AU - Ramondetta, Lois M.
AU - Frumovitz, Michael
N1 - Funding Information:
This work was supported by the National Institutes of Health/National Cancer Institute under award number P30CA016672. Dr. Frumovitz receives research funding from Navidea and Novadaq and honorarium from Novadaq, Genetech, and Johnson and Johnson.
Publisher Copyright:
© 2018 American Association of Gynecologic Laparoscopists
PY - 2019/1
Y1 - 2019/1
N2 - Study Objective: To compare the accuracy of frozen section diagnosis of borderline ovarian tumors among 3 distinct types of hospital—academic hospital with gynecologic pathologists, academic hospital with nongynecologic pathologists, and community hospital with nongynecologic pathologists—and to determine if surgical staging alters patient care or outcomes for women with a frozen section diagnosis of borderline ovarian tumor. Design: Retrospective study (Canadian Task Force classification II-1). Setting: Tertiary care, academic, and community hospitals. Patients: Women with an intraoperative frozen section diagnosis of borderline ovarian tumor at 1 of 3 types of hospital from April 1998 through June 2016. Interventions: Comparison of final pathology with intraoperative frozen section diagnosis. Measurements and Main Results: Two hundred twelve women met the inclusion criteria. The frozen section diagnosis of borderline ovarian tumor correlated with the final pathologic diagnosis in 192 of 212 cases (90.6%), and the rate of correlation did not differ among the 3 hospital types (p =.82). Seven tumors (3.3%) were downgraded to benign on final pathologic analysis and 13 (6.1%) upgraded to invasive carcinoma. The 3 hospital types did not differ with respect to the proportion of tumors upgraded to invasive carcinoma (p =.62). Mucinous (odds ratio, 7.1; 95% confidence interval, 2.1–23.7; p =.002) and endometrioid borderline ovarian tumors (odds ratio, 32.4; 95% confidence interval, 1.8–595.5; p =.02) were more likely than serous ovarian tumors to be upgraded to carcinoma. Only 88 patients (41.5%) underwent lymphadenectomy, and only 1 (1.1%) had invasive carcinoma in a lymph node. Conclusions: A frozen section diagnosis of borderline ovarian tumor correlates with the final pathologic diagnosis in a variety of hospital types.
AB - Study Objective: To compare the accuracy of frozen section diagnosis of borderline ovarian tumors among 3 distinct types of hospital—academic hospital with gynecologic pathologists, academic hospital with nongynecologic pathologists, and community hospital with nongynecologic pathologists—and to determine if surgical staging alters patient care or outcomes for women with a frozen section diagnosis of borderline ovarian tumor. Design: Retrospective study (Canadian Task Force classification II-1). Setting: Tertiary care, academic, and community hospitals. Patients: Women with an intraoperative frozen section diagnosis of borderline ovarian tumor at 1 of 3 types of hospital from April 1998 through June 2016. Interventions: Comparison of final pathology with intraoperative frozen section diagnosis. Measurements and Main Results: Two hundred twelve women met the inclusion criteria. The frozen section diagnosis of borderline ovarian tumor correlated with the final pathologic diagnosis in 192 of 212 cases (90.6%), and the rate of correlation did not differ among the 3 hospital types (p =.82). Seven tumors (3.3%) were downgraded to benign on final pathologic analysis and 13 (6.1%) upgraded to invasive carcinoma. The 3 hospital types did not differ with respect to the proportion of tumors upgraded to invasive carcinoma (p =.62). Mucinous (odds ratio, 7.1; 95% confidence interval, 2.1–23.7; p =.002) and endometrioid borderline ovarian tumors (odds ratio, 32.4; 95% confidence interval, 1.8–595.5; p =.02) were more likely than serous ovarian tumors to be upgraded to carcinoma. Only 88 patients (41.5%) underwent lymphadenectomy, and only 1 (1.1%) had invasive carcinoma in a lymph node. Conclusions: A frozen section diagnosis of borderline ovarian tumor correlates with the final pathologic diagnosis in a variety of hospital types.
KW - Borderline ovarian tumor
KW - Frozen section
KW - Hospital type
KW - Ovarian cancer
KW - Staging
UR - http://www.scopus.com/inward/record.url?scp=85047219962&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047219962&partnerID=8YFLogxK
U2 - 10.1016/j.jmig.2018.04.005
DO - 10.1016/j.jmig.2018.04.005
M3 - Article
C2 - 29680231
AN - SCOPUS:85047219962
SN - 1553-4650
VL - 26
SP - 87
EP - 93
JO - Journal of Minimally Invasive Gynecology
JF - Journal of Minimally Invasive Gynecology
IS - 1
ER -